Trends and Marketing Analysis of Osteoporosis Therapeutic Drugs in Uzbekistan

Ziyodakhon Kadyrkhanovna Yusupova; Dilfuza Tulkunovna Saipova

doi:10.36948/ijfmr.2025.v07i06.59707

Trends and Marketing Analysis of Osteoporosis Therapeutic Drugs in Uzbekistan

Author(s)	Ms. Ziyodakhon Kadyrkhanovna Yusupova, Prof. Dr. Dilfuza Tulkunovna Saipova
Country	Uzbekistan
Abstract	Objective. To assess the current stage and main tendencies of the development of anti-osteoporotic drugs in relation to their market value. Materials and methods. The research used systematic, comparative and content analysis methods to examine the range of products offered by the group under study. In addition: Graphical method, generalisation approach, provide explanations and facilitate discussion. The study was based on data from the State Register of Medicines and Medical Devices of the Republic of Uzbekistan for 2020-2024. Results. According to the analysis of anti-osteoporotic drugs, the rates of vitamin D and its derivatives increased over 5 years, while calcium-saving drugs, on the contrary, decreased. No significant changes were observed in the estrogen gestagen and anabolic steroid groups. The results of country analysis showed that the main competitors among imported drugs are India and Turkey. Also, according to the results of the study of dosage forms, it was revealed that in the groups of calcium preparations and estrogen and estrogen-gestagen preparations, tablets were the most popular in the group of vitamin D and its derivatives - drops. However, the most frequently mentioned INNs were zoledronic acid, cholecalciferol, calcium carbonate + cholecalciferol, estradiol and nandrolone decanoate were identified. Conclusions. The dynamics of registration of the assortment of anti-osteoporotic drugs offered in the pharmaceutical market of the Republic of Uzbekistan by years, countries, dosage forms, and indices on INN were analysed. It was found that most of the mentioned drugs correspond to foreign drugs. Moreover, it was found that there are no analogues of some drugs for the INN of domestic production in some groups.
Keywords	: osteoporosis, assortment, marketing analysis, pharmaceutical market, bisphosphonates, estrogens, Selective estrogen receptor modulators (SERMs), Denosumab.
Field	Medical / Pharmacy
Published In	Volume 7, Issue 6, November-December 2025
Published On	2025-11-18
DOI	https://doi.org/10.36948/ijfmr.2025.v07i06.59707

View / Download PDF File

E-ISSN 2582-2160

doi

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads

Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 8 Isu 3 Cover Page Vol 8 Isu 2 Cover Page Vol 8 Isu 2

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9687-828-838	editor@ijfmr.com

International Journal For Multidisciplinary Research

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Trends and Marketing Analysis of Osteoporosis Therapeutic Drugs in Uzbekistan

Share this